US pharmaceutical company stockpiling its antiviral drug for monkeypox

First published at 10:11 UTC on May 21st, 2022.

A US pharmaceutical company says it’s in talks with European authorities seeking to stockpile its antiviral drug for monkeypox amid an "unusual international outbreak" of the virus, even though they openly admit the risk is low, if any.

CategoryNone
SensitivityNormal - Content that is suitable for ages 16 and over